- Previous Close
0.0030 - Open
0.0020 - Bid 0.0020 x --
- Ask 0.0030 x --
- Day's Range
0.0020 - 0.0030 - 52 Week Range
0.0020 - 0.0150 - Volume
110,000 - Avg. Volume
368,783 - Market Cap (intraday)
1.19M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date Aug 30, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
BPH Global Ltd, together with its subsidiaries, engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Malaysia. Its products include Caulerpa Lentillifera, a sea grape extract; Dendrobium Officinale Kimura et Migo, an orchid; Resina, a Daemonorops Draco Blume extract; and Cannabis Sativa, an industrial hemp. The company was formerly known as Stemcell United Limited and changed its name to BPH Global Ltd in June 2023. BPH Global Ltd was incorporated in 1984 and is headquartered in Melbourne, Australia.
www.scu.com.sg--
Full Time Employees
June 30
Fiscal Year Ends
Sector
Recent News: BP8.AX
View More
Performance Overview: BP8.AX
Trailing total returns as of 9/2/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BP8.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BP8.AX
View MoreValuation Measures
Market Cap
1.19M
Enterprise Value
995.02k
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.44k
Price/Book (mrq)
91.17
Enterprise Value/Revenue
7.08k
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-99.30%
Return on Equity (ttm)
--
Revenue (ttm)
109.97k
Net Income Avi to Common (ttm)
-1.6M
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
133.62k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-1.01M
Company Insights: BP8.AX
BP8.AX does not have Company Insights